Arthur Klausner

Life Sciences Executive and Investor

An experienced life sciences executive and investor, Arthur Klausner currently serves as Executive Chairman of Concarlo Therapeutics (oncology). He is the former CEO of Goldilocks Therapeutics (nephrology), Gem Pharmaceuticals (oncology), and Jade Therapeutics (ophthalmology). He currently serves as a board member of Monopar Therapeutics (Nasdaq: MNPR). Before his operating roles, Arthur spent a total of 18 years as a life sciences venture capitalist at Domain Associates and Pappas Ventures.